Novartis AG
Methods for treating disease using inhibitors of bone morphogenetic protein 6 (BMP6)

Last updated:

Abstract:

The present invention relates methods of treatment using BMP6 antagonists.

Status:
Grant
Type:

Utility

Filling date:

13 Jun 2017

Issue date:

6 Sep 2022